Published • loading... • Updated
Lower Right Heart Reserve Linked to Worse Outcomes After Interatrial Shunting in Heart Failure
Summary by Medscape
2 Articles
2 Articles
Boston – The SGLT-2 inhibitor dapagliflozin, developed to treat type 2 diabetes, is increasingly being used to protect people with reduced cardiac output from heart failure. This protective effect was demonstrated in a study published in Nature Medicine (2026; DOI: 10.1038/s41591-026-04439-x) in individuals with...
Lower Right Heart Reserve Linked to Worse Outcomes After Interatrial Shunting in Heart Failure
In patients with heart failure, a lower TAPSE/PASP ratio is linked to higher rates of cardiovascular death or heart failure hospitalisation after interatrial shunting. Medscape News UK
·United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
